Insider Transaction Report - Simon Farrell

This filing reports a transaction by Simon Farrell, who is a Director at Serina Therapeutics, Inc. The transaction occurred on July 22, 2026. The filing indicates that Mr. Farrell owns no securities directly, but the form is related to his position as a director. The filing was signed on July 23, 2026, by Steven Ledger as Attorney in Fact. This is a Form 3 filing, which is an initial statement of beneficial ownership of securities.